Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease

The Duke Clinical Research Institute (DCRI) is leading a new clinical study to optimize care for people with type 2 diabetes and cardiovascular disease through evaluation of a multidisciplinary approach at cardiology clinics across the U.S. The research https://www.prnewswire.com/news-releases/boehringer-ingelheim-and-lilly-partner-with-duke-clinical-research-institute-to-advance-multidisciplinary-care-for-people-with-type-2-diabetes-and-cardiovascular-disease-300764687.html